Chattem explores homeopathy
This article was originally published in The Tan Sheet
Executive Summary
Firm "is working to develop alternate formulations for Sportscreme and Aspercreme" in case FDA does not look favorably on available clinical data for active ingredient trolamine salicylate, Chattem says in recent 10-K filing. Firm also states it could market the pain relief products as homeopathic agents, or submit new studies on ingredient's safety and efficacy. In May 2001, FDA recommended Chattem adjust the protocol for a proposed study to more accurately reflect the actual use of topical analgesics (1"The Tan Sheet" May 7, 2001, p. 4)...